标题/作者	年份
Features, evaluation, and treatment of coronavirus (COVID-19) M Cascella, M Rajnik, A Aleem, S Dulebohn, R Di Napoli StatPearls	2023
6-month consequences of COVID-19 in patients discharged from hospital: a cohort study C Huang, L Huang, Y Wang, X Li, L Ren, X Gu, L Kang, L Guo, M Liu, ... The Lancet 397 (10270), 220-232	2021
Association between administration of systemic corticosteroids and mortality among critically ill patients with COVID-19: a meta-analysis JAC Sterne, S Murthy, JV Diaz, AS Slutsky, J Villar, DC Angus, D Annane, ... Jama 324 (13), 1330-1341	2020
Effect of remdesivir vs standard care on clinical status at 11 days in patients with moderate COVID-19: a randomized clinical trial CD Spinner, RL Gottlieb, GJ Criner, JRA López, AM Cattelan, ... Jama 324 (11), 1048-1057	2020
Tocilizumab in patients hospitalized with Covid-19 pneumonia C Salama, J Han, L Yau, WG Reiss, B Kramer, JD Neidhart, GJ Criner, ... New England Journal of Medicine 384 (1), 20-30	2021
Effect of dexamethasone on days alive and ventilator-free in patients with moderate or severe acute respiratory distress syndrome and COVID-19: the CoDEX randomized clinical trial BM Tomazini, IS Maia, AB Cavalcanti, O Berwanger, RG Rosa, VC Veiga, ... Jama 324 (13), 1307-1316	2020
Infectious Diseases Society of America Guidelines on the treatment and management of patients with coronavirus disease 2019 (COVID-19) A Bhimraj, RL Morgan, AH Shumaker, V Lavergne, L Baden, VCC Cheng, ... Clinical Infectious Diseases, ciaa478	2020
Genetic mechanisms of critical illness in COVID-19 E Pairo-Castineira, S Clohisey, L Klaric, AD Bretherick, K Rawlik, D Pasko, ... Nature 591 (7848), 92-98	2021
Individuals with obesity and COVID‐19: a global perspective on the epidemiology and biological relationships BM Popkin, S Du, WD Green, MA Beck, T Algaith, CH Herbst, RF Alsukait, ... Obesity reviews 21 (11), e13128	2020
Severe COVID-19 is marked by a dysregulated myeloid cell compartment J Schulte-Schrepping, N Reusch, D Paclik, K Baßler, S Schlickeiser, ... Cell 182 (6), 1419-1440. e23	2020
Drug treatments for covid-19: living systematic review and network meta-analysis RAC Siemieniuk, JJ Bartoszko, D Zeraatkar, E Kum, A Qasim, ... bmj 370	2020
Therapeutic anticoagulation with heparin in noncritically ill patients with Covid-19 ATTACC, ACTIV-4a, and REMAP-CAP Investigators New England Journal of Medicine 385 (9), 790-802	2021
Effect of tocilizumab vs usual care in adults hospitalized with COVID-19 and moderate or severe pneumonia: a randomized clinical trial O Hermine, X Mariette, PL Tharaux, M Resche-Rigon, R Porcher, ... JAMA internal medicine 181 (1), 32-40	2021
A dynamic COVID-19 immune signature includes associations with poor prognosis AG Laing, A Lorenc, I Del Molino Del Barrio, A Das, M Fish, L Monin, ... Nature medicine 26 (10), 1623-1635	2020
Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: A pilot randomized clinical study ME Castillo, LME Costa, JMV Barrios, JFA Díaz, JL Miranda, R Bouillon, ... The Journal of steroid biochemistry and molecular biology 203, 105751	2020
COVID-19 and multisystem inflammatory syndrome in children and adolescents L Jiang, K Tang, M Levin, O Irfan, SK Morris, K Wilson, JD Klein, ZA Bhutta The Lancet Infectious Diseases 20 (11), e276-e288	2020
COVID-19 is, in the end, an endothelial disease P Libby, T Lüscher European heart journal 41 (32), 3038-3044	2020
Cytokine elevation in severe and critical COVID-19: a rapid systematic review, meta-analysis, and comparison with other inflammatory syndromes DE Leisman, L Ronner, R Pinotti, MD Taylor, P Sinha, CS Calfee, ... The Lancet Respiratory Medicine 8 (12), 1233-1244	2020
Effect of hydrocortisone on mortality and organ support in patients with severe COVID-19: the REMAP-CAP COVID-19 corticosteroid domain randomized clinical trial DC Angus, L Derde, F Al-Beidh, D Annane, Y Arabi, A Beane, ... Jama 324 (13), 1317-1329	2020
Lopinavir–ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial PW Horby, M Mafham, JL Bell, L Linsell, N Staplin, J Emberson, ... The Lancet 396 (10259), 1345-1352	2020

1 - 20

计算机程序会自动估算并确定日期和引用次数。